This is a past Event
Nina Yin, Health Policy Working Group
Murphy Institute Post-doctoral Fellow
“Pharmaceuticals, Incremental Innovation and Market Exclusivity”
This Event is by Invitation Only
202-Rechler Conference Room, Lavin-Bernick Center Uptown Campus
Meeting time is 12:00 – 1:00pm. Lunch will be provided. The meeting is open only to members of the Health Policy Working Group.
About the Speaker
Dr. Yin is one of the postdoc teaching fellows in the Murphy Institute and Department of Economics at Tulane University from 2013-2015. She obtained her PhD degree from Toulouse School of Economics, France in 2013. Before that, she obtained an M.A. from the China Center for Economic Research, Peking University. Her research interests involve health economics, empirical industrial organization and the economics of innovation and intellectual property. Her current work focuses on policy issues related to the patent and data exclusivities granted to the incremental innovation in the pharmaceutical industry. Policy makers wonder whether it’s beneficial to grant patent and data exclusivities to the incremental innovations of the existing drugs. On the one hand, it encourages investments in R&D for drug improvements, which is better tailored to patients’ needs and improves drug safety and efficacy; on the other hand, the market exclusivity permits brand drugs to dominate the market with monopoly pricing, which brings about consumer surplus loss. Her work measures these two blocks of value and provides interesting policy implications.